Kumagai Y, Kato J I, Hoshino K, Akasaka T, Sato K, Ikeda H
Department of Molecular Biology, University of Tokyo, Japan.
Antimicrob Agents Chemother. 1996 Mar;40(3):710-14. doi: 10.1128/AAC.40.3.710.
Escherichia coli quinolone-resistant strains with mutations of the parC gene, which codes for a subunit of topoisomerase IV, were isolated from a quinolone-resistant gyrA mutant of DNA gyrase. Quinolone-resistant parC mutants were also identified among the quinolone-resistant clinical strains. The parC mutants became susceptible to quinolones by introduction of a parC+ plasmid. Introduction of the multicopy plasmids carrying the quinolone-resistant parC mutant gene resulted in an increase in MICs of quinolones for the parC+ and quinolone-resistant gyrA strain. Nucleotide sequences of the quinolone-resistant parC mutant genes were determined, and missense mutations at position Gly-78, Ser-80, or Glu-84, corresponding to those in the quinolone-resistance-determining region of DNA gyrase, were identified. These results indicate that topoisomerase IV is a target of quinolones in E. coli and suggest that the susceptibility of E. coli cells to quinolones is determined by sensitivity of the targets, DNA gyrase and topoisomerase IV.
从DNA旋转酶的喹诺酮抗性gyrA突变体中分离出具有parC基因突变的大肠杆菌喹诺酮抗性菌株,parC基因编码拓扑异构酶IV的一个亚基。在喹诺酮抗性临床菌株中也鉴定出了喹诺酮抗性parC突变体。通过导入parC+质粒,parC突变体对喹诺酮变得敏感。携带喹诺酮抗性parC突变基因的多拷贝质粒的导入导致parC+和喹诺酮抗性gyrA菌株的喹诺酮最低抑菌浓度(MIC)增加。测定了喹诺酮抗性parC突变基因的核苷酸序列,并鉴定出在第78位甘氨酸、第80位丝氨酸或第84位谷氨酸处的错义突变,这些位置与DNA旋转酶的喹诺酮抗性决定区域中的突变相对应。这些结果表明拓扑异构酶IV是大肠杆菌中喹诺酮的作用靶点,并提示大肠杆菌细胞对喹诺酮的敏感性由靶点DNA旋转酶和拓扑异构酶IV的敏感性决定。